Visiting Stanford's Innovative Medicines Accelerator
- blonca9
- Apr 17, 2024
- 1 min read
Chaitan Khosla, Director of the Innovative Medicines Accelerator, describes how Stanford goes extra lengths to turn its research into licensable assets for the biopharmaceutical industry.